Publications
5808 Results
- Journal / Conference
- Blood 81(8):2187-2193
- Year
- 1993
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8612
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with recurrent leukemia who were not in first remission: A Southwest Onology Group study.
- Journal / Conference
- JCO 11:1276-1285
- Year
- 1993
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8616 (INT-0072)
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
- Journal / Conference
- IND 11:47-51
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8730
Amonafide treatment of refractory esophageal cancer: A Southwest Oncology Group study.
- Journal / Conference
- JCO 11(5):873-878
- Year
- 1993
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8738
Evaluation of cisplatin intensity in metastatic non-small cell lung cancer: A phase III study of the Southwest Oncology Group.
- Journal / Conference
- Journal of Thoracic and Cardiovascular Surgery 105(1):97-106
- Year
- 1993
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8805
Surgical resection of stage IIIA and stage IIIB non-small cell lung cancer after concurrent induction chemoradiotherapy.
- Journal / Conference
- Leukemia 7(3):361-365
- Year
- 1993
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8833
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 81(11):3509-3513
- Year
- 1993
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8857
Prolonged, alternating chemotherapy for extensive small cell lung cancer: A Southwest Oncology Group study.
- Journal / Conference
- IND 11:81-83
- Year
- 1993
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8915
Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer: A Southwest Oncology Group study.
- Journal / Conference
- Science 259:968-971
- Year
- 1993
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
- Journal / Conference
- JASA 88(422):457-467
- Year
- 1993